The agencies replace Munro & Forster Communications, which formerly
promoted both gastro and natural health brands for Boehringer and which has now ceased to work for the company after six years.
Virgo Health’s remit includes laxative Dulco-lax, with the agency planning a PR campaign to ‘create interest in and discussion about’ the historically taboo subject of constipation. Previous campaigns for Dulco-lax have carried a similar theme; for example, Boehringer launched a campaign in 2003 that flagged up research showing a shyness among women about discussing the problem.
Virgo Health’s brief also includes promoting an as-yet-undisclosed gastro product set to launch later this year. NBPR, meanwhile, has been appointed to promote Actimind and Activit G, plus Pharmaton. The agency has promoted BI’s Antistax for the past year and continues to do so.
Activit G, an orange drink that comes in fizzy-tab form, will launch this month.
Actimind is a capsule designed to help concentration while Antistax, which comes in capsule and gel form, is designed to lessen tension in the legs.
Virgo Health joint MD Sarah Matthew leads the account alongside associate director Caroline Fielding, who has joined the agency from Shire Health International – which was appointed to handle global PR for Dulco-lax two months ago.
Virgo – which also plugs Micardis – and NBPR report to Boehringer senior product manager Kate Evans.